In Brief: CryoLife
This article was originally published in The Gray Sheet
CryoLife: Acquires patent rights to a stentless pulmonary porcine heart valve for use in pediatric applications. Use of the valve, which was developed by English heart surgeon Donald Ross, "would provide pediatric cardiovascular surgeons with the ability to `series' a number of heart valve implants as infants and young children rapidly outgrow implanted valves as they mature," CryoLife says. CryoLife plans to commence European clinical trials of the Ross valve in 1997...
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.